Colchicine in Patients with Chronic Coronary Disease
2020 · New England Journal of Medicine · 1,939 citations
https://doi.org/10.1056/nejmoa2021372
S
Stefan M. Nidorf
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
76
Papers
5.1K
Citations
26
h-index
36
i10-index
Stefan M. Nidorf is an academic researcher from Harry Perkins Institute of Medical Research. The author has contributed to research in topics: Inflammasome and immune disorders & Atherosclerosis and Cardiovascular Diseases & Lipoproteins and Cardiovascular Health. The author has an h-index of 26, co-authored 65 publications.
ORCID: 0000-0002-2226-538XPapers by this author
worksAnti-inflammatory therapy with canakinumab for atherosclerotic disease: lessons from the CANTOS trial
2018 · Journal of Thoracic Disease · 57 citations
https://doi.org/10.21037/jtd.2018.01.119
Drivers of mortality in patients with chronic coronary disease in the low-dose colchicine 2 trial
2022 · International Journal of Cardiology · 30 citations
https://doi.org/10.1016/j.ijcard.2022.12.026
The Effect of Years-Long Exposure to Low-Dose Colchicine on Renal and Liver Function and Blood Creatine Kinase Levels: Safety Insights from the Low-Dose Colchicine 2 (LoDoCo2) Trial
2022 · Clinical Drug Investigation · 18 citations
https://doi.org/10.1007/s40261-022-01209-8
Colchicine and diabetes in patients with chronic coronary artery disease: insights from the LoDoCo2 randomized controlled trial
2023 · Frontiers in Cardiovascular Medicine · 12 citations
https://doi.org/10.3389/fcvm.2023.1244529
Cost-effectiveness of low-dose colchicine in patients with chronic coronary disease in The Netherlands
2024 · European Heart Journal - Quality of Care and Clinical Outcomes · 5 citations
https://doi.org/10.1093/ehjqcco/qcae021
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat